231P - Cost-effectiveness of olaparib vs routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
| Autor: | Tan, D.S., Chan, J.J., Loke, J.K., Hettle, R., Ghosh, W., Viswambaram, A., Yu, C.C. |
|---|---|
| Zdroj: | In Annals of Oncology November 2019 30 Supplement 9:ix79-ix80 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|